Načítá se...
Pyoderma gangrenosum–like ulceration of the lower extremity secondary to sunitinib therapy: a case report
Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor used for the treatment of multiple different types of malignancies. Serious grade 3–4 adverse events occur in <10% of the patient population and usually improve with dose reduction. One of the more rarely reported side effects of su...
Uloženo v:
| Vydáno v: | SAGE Open Med Case Rep |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6024264/ https://ncbi.nlm.nih.gov/pubmed/29977559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X18783048 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|